Abstract:The increasing burden of respiratory disease is a rising concern in India. Although chronic colonisation is primarily caused by pathogenic fungi, the common environmental fungi also play an important role in developing sensitisation. This study aims to examine the allergenic potency of mycelial proteins of a common indoor fungus Aspergillus ochraceus to a selected atopic patient cohort as well as to identify the novel IgE-binding proteins through an immunoproteomic approach. 1-D and 2-D IgE specific western blot detected the IgE reactive proteins which were identified through MALDI-TOF/TOF and manual de novo peptide sequencing. The results revealed the detection of 10 cross-reactive IgE-binding proteins. Cluster analysis of 1-D immunoblot with individual patient sera identified NADP(+)-dependent glycerol dehydrogenase (GldB) homologous protein as a major allergen, which was further purified and the allergenicity was assessed. Other IgE-binding proteins showed homology with allergens like short-chain dehydrogenase, NAD-dependent mannitol dehydrogenase, and subtilisin-like serine protease. GldB purified under native conditions showed IgE reactivity amongst the selected patient cohort, which is reported for the first time in this study. The identified IgE-binding proteins can act as candidate molecules for developing hypoallergenic vaccines for designing specific immunotherapeutic techniques to fungal allergy. THE SIGNIFICANCE OF THE STUDY: Exposure to environmental fungal allergens is directly associated with promoting allergic response as well as complicating existing respiratory disease, leading to poor respiratory health. Amongst others, Aspergillus spp. contributes to the majority of the fungal derived atopic diseases. Aspergillus ochraceus is a common indoor mould in India, however, its allergenic potency was not explored till date. In this study, we establish A. ochraceus responsible to cause an allergic response to susceptible individuals and identified 10 IgE-binding proteins using an immunoproteomics approach for the first time. A. ochraceus being unsequenced, a homology-driven proteomics approach was used to identify the IgE-binding proteins which can be extended to identify proteins from other unsequenced species. The information on the IgE-binding proteins could be used as a step towards characterising them by molecular and structural methods to investigate the molecular basis of allergenicity. This will also help to enrich the existing database of allergenic proteins and pave a way towards developing therapeutic avenues.

In silico B-cell epitope prediction and molecular docking of Aspergillus allergens targeting improved ABPA diagnosis

Role of Aspergillus Fumigatus-Specific IgE in the Diagnosis of Allergic Bronchopulmonary Aspergillosis

Clinical Characteristics of Allergic Bronchopulmonary Aspergillosis

Successful Treatments For Allergic Bronchopulmonary Aspergillosis In Non-Cystic Fibrosis Children: A Report Of Two Cases And A Literature Review

Advance in Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis

Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics

Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma

Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis

Revised clinical practice guidelines for diagnosing, classifying, and treating allergic bronchopulmonary aspergillosis/mycoses: a Delphi statement from the ISHAM-ABPA working group

Identification of Minimal Motifs of Linear B Cell Epitope on Asp F3 and Asp F4 of Aspergillus F Umigatus

Identification of Immunogenic Antigens from Aspergillus Fumigatus by Direct Multiparameter Characterization of Specific Conventional and Regulatory CD4+ T Cells.

[Development in diagnostic criteria for allergic bronchopulmonary aspergillosis].

A Retrospective Study of Patients with a Delayed Diagnosis of Allergic Bronchopulmonary Aspergillosis/allergic Bronchopulmonary Mycosis

Identifying novel allergens from a common indoor mould Aspergillus ochraceus

Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis

[Significance of Aspergillus Fumigatus-Specific IgG in the Diagnosis of Allergic Bronchopulmonary Aspergillosis].

Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis

Clinical Analysis of 20 Cases of Allergic Bronchopulmonary Aspergillosis.

FeNO, a potential biomarker for evaluating glucocorticoids treatment and prognosis in ABPA

Population prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in COPD subjects in North India

Systems-wide analysis of A. fumigatus using kinetic modeling of metabolic pathways to identify putative drug targets